Quick Answer
Benitec Biopharma Inc. reported Net Income of -$37.92 million for fiscal year 2025.
Benitec Biopharma Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$37.92M | -74.3% |
| 2024 | -$21.75M | -11.2% |
| 2023 | -$19.56M | -7.4% |
| 2022 | -$18.21M | -31.2% |
| 2021 | -$13.88M | -67.8% |
| 2020 | -$8.27M | -417.1% |
| 2019 | $2.61M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$11.84M | -23.9% | -32.0% |
| September 30, 2025 | -$8.96M | -77.2% | +4.2% |
| March 31, 2025 | -$9.35M | -118.6% | +2.1% |
| December 31, 2024 | -$9.55M | -40.5% | -88.8% |
| September 30, 2024 | -$5.06M | +15.0% | -18.2% |
| March 31, 2024 | -$4.28M | +2.7% | +37.1% |
| December 31, 2023 | -$6.80M | -25.6% | -14.2% |
| September 30, 2023 | -$5.95M | -16.9% | -35.4% |
- Benitec Biopharma Inc. showed a decrease of -74.3% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Benitec Biopharma Inc.’s net income has declined by 1553.3% (from $2.61 million to -$37.92 million).
- The most recent figure is from Benitec Biopharma Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: